Analysts forecast that Cerner Co. (NASDAQ:CERN) will report $1.34 billion in sales for the current quarter, Zacks reports. Ten analysts have provided estimates for Cerner’s earnings. The highest sales estimate is $1.35 billion and the lowest is $1.31 billion. Cerner posted sales of $1.26 billion during the same quarter last year, which would indicate a positive year-over-year growth rate of 6.3%. The business is expected to report its next quarterly earnings report on Thursday, April 26th.
According to Zacks, analysts expect that Cerner will report full year sales of $1.34 billion for the current financial year, with estimates ranging from $5.45 billion to $5.61 billion. For the next year, analysts anticipate that the firm will post sales of $6.02 billion per share, with estimates ranging from $5.88 billion to $6.16 billion. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that that provide coverage for Cerner.
Cerner (NASDAQ:CERN) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $0.58 EPS for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.03). Cerner had a return on equity of 16.82% and a net margin of 16.86%. The business had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period last year, the firm posted $0.61 EPS. Cerner’s quarterly revenue was up 4.5% on a year-over-year basis.
In other news, Director William D. Zollars sold 4,100 shares of the stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $62.16, for a total value of $254,856.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Vice Chairman Clifford W. Illig sold 307,700 shares of the stock in a transaction dated Thursday, March 8th. The shares were sold at an average price of $64.52, for a total value of $19,852,804.00. Following the completion of the sale, the insider now directly owns 1,229,719 shares of the company’s stock, valued at approximately $79,341,469.88. The disclosure for this sale can be found here. In the last three months, insiders sold 541,800 shares of company stock valued at $34,353,860. Insiders own 13.11% of the company’s stock.
Several institutional investors have recently made changes to their positions in the stock. Cedar Hill Associates LLC bought a new stake in shares of Cerner during the 4th quarter valued at about $200,000. Xact Kapitalforvaltning AB boosted its position in shares of Cerner by 3.7% during the 4th quarter. Xact Kapitalforvaltning AB now owns 47,338 shares of the company’s stock valued at $3,190,000 after purchasing an additional 1,702 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its position in shares of Cerner by 2.0% during the 4th quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 385,067 shares of the company’s stock valued at $25,950,000 after purchasing an additional 7,558 shares in the last quarter. We Are One Seven LLC bought a new stake in shares of Cerner during the 4th quarter valued at about $576,000. Finally, Compagnie Lombard Odier SCmA boosted its position in shares of Cerner by 889.5% during the 4th quarter. Compagnie Lombard Odier SCmA now owns 10,885 shares of the company’s stock valued at $733,000 after purchasing an additional 9,785 shares in the last quarter. Institutional investors own 78.56% of the company’s stock.
Cerner (NASDAQ CERN) opened at $63.05 on Wednesday. Cerner has a fifty-two week low of $54.49 and a fifty-two week high of $73.86. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.01 and a quick ratio of 2.99. The stock has a market capitalization of $21,499.09, a PE ratio of 24.53, a price-to-earnings-growth ratio of 1.88 and a beta of 0.93.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.